Skip to content

Author

Jing-Yi Cheng

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Tumor cell-derived SPP1 reprograms fibroblasts into CAFs via CD44/PI3K/AKT/Twist signaling axis to promote immune barrier formation in oral squamous cell carcinoma.

An important molecular circuit underlying stromal remodeling in OSCC is delineated, the disruption of which can potentially prevent the CAF-driven immune barrier formation and overcome therapeutic resistance in OSCC.

Qian Tang, Jing-Yi Cheng, Yu-Die Lu et al. · 0 citations
Review Oct 2026

Mitochondrial transfer in cancer-immune crosstalk.

This review delineates how mitochondrial transfer exerts dual effects on antitumor immunity: tumor cells hijack functional mitochondria from T cells, macrophages, and stromal cells to fuel their proliferation and therapy resistance, while simultaneously delivering mutant mitochondria to immune cells to drive exhaustion...

Yu-Han Chen, Zhan-Gui Tang, Jing-Yi Cheng · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.